thiouracil has been researched along with Glioblastoma* in 1 studies
1 other study(ies) available for thiouracil and Glioblastoma
| Article | Year |
|---|---|
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.
Thiouracil and thiocytosine are important heterocyclic pharmacophores having pharmacological diversity. Antitumor and antiviral activity is commonly associated with thiouracil and thiocytosine derivatives, which are well known fragments for adenosine receptor affinity with many associated pharmacological properties. In this respect, 33 novel compounds have been synthesized in two groups: 24 thiouracil derivatives (4a-x) and 9 thiocytosine derivatives (5a-i). Antitumor activity of all the compounds was determined in the U87 MG glioblastoma cell line. Compound 5e showed an anti-proliferative IC Topics: Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytosine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Receptors, Purinergic P1; Structure-Activity Relationship; Thiouracil | 2021 |